Isothermal microcalorimetry: A novel method for real-time determination of antifungal susceptibility of Aspergillus species

Clinical Microbiology and Infection

Volumn 18, Issue 7, 2012, Pages

  Furustrand Tafin, U ^a   Clauss, M ^a,d   Hauser, P M ^a   Bille, J ^a   Meis, J F ^b,c   Trampuz, A ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c CANISIUS WILHELMINA HOSPITAL   (Netherlands)

^d Kantonsspital Liestal   (Switzerland)

Author keywords

Antifungals; Aspergillus spp.; Heat production; Microcalorimetry; Susceptibility testing

Indexed keywords

AMPHOTERICIN B; ANIDULAFUNGIN; CASPOFUNGIN; POSACONAZOLE; VORICONAZOLE;

ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; ASPERGILLUS FUMIGATUS; DILUTION; FUNGUS GROWTH; MICROCALORIMETRY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; THERMOGENESIS;

ASPERGILLUS; ASPERGILLUS FUMIGATUS;

EID: 84862602581     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2012.03854.x     Document Type: Article

References (20)

1. Lass-Florl C. The changing face of epidemiology of invasive fungal disease in Europe. Mycoses 2009; 52: 197-205.
2. Clinical Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi, 2nd edn. Approved Standard. CLSI document M38-A2: Wayne, PA: CLSI, 2008.
3. Subcommittee on Antifungal Susceptibility Testing of the E, European Committee for Antimicrobial Susceptibility Testing. EUCAST Technical Note on the method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia-forming moulds. Clin Microbiol Infect 2008;14:982-984.
4. Davey KG, Szekely A, Johnson EM, Warnock DW. Comparison of a new commercial colorimetric microdilution method with a standard method for in-vitro susceptibility testing of Candida spp. and Cryptococcus neoformans. J Antimicrob Chemother 1998; 42: 439-444.
5. Guinea J, Pelaez T, Alcala L, Bouza E. Comparison of Sensititre YeastOne with the NCCLS M38-A microdilution method to determine the activity of amphotericin B, voriconazole, and itraconazole against clinical isolates of Aspergillus fumigatus. Diagn Microbiol Infect Dis 2006; 56: 53-55.
6. Patel R, Mendrick C, Knapp CC, Grist R, McNicholas PM. Clinical evaluation of the Sensititre YeastOne plate for testing susceptibility of filamentous fungi to posaconazole. J Clin Microbiol 2007; 45: 2000-2001.
7. Wadsö I. Isothermal microcalorimety: current problems and prospects. J Therm Anal Calorim 2001; 64: 75-84.
8. Baldoni D, Hermann H, Frei R, Trampuz A, Steinhuber A. Performance of microcalorimetry for early detection of methicillin resistance in clinical isolates of Staphylococcus aureus. J Clin Microbiol 2009; 47: 774-776.
9. von AhU, Wirz D, Daniels AU. Isothermal micro calorimetry-a new method for MIC determinations: results for 12 antibiotics and reference strains of E. coli and S. aureus. BMC Microbiol 2009; 9: 106.
10. Manneck T, Braissant O, Haggenmuller Y, Keiser J. Isothermal microcalorimetry to study drugs against Schistosoma mansoni. J Clin Microbiol 2011; 49: 1217-1225.
11. Kurtz MB, Heath IB, Marrinan J, Dreikorn S, Onishi J, Douglas C. Morphological effects of lipopeptides against Aspergillus fumigatus correlate with activities against (1, 3)-beta-D-glucan synthase. Antimicrob Agents Chemother 1994; 38: 1480-1489.
12. Meletiadis J, Meis JF, Mouton JW, Verweij PE. Analysis of growth characteristics of filamentous fungi in different nutrient media. J Clin Microbiol 2001; 39: 478-484.
13. Katarao AOH, Takahashi K. Calorimetric analysis of the effects of penicillin G, ampicillin and polymyxin B on the growth of Escherichia coli. Agric Biol Chem 1988; 52: 2279-2285.
14. Antoce OA, Antoce V, Takahashi K, Yoshizako F. Quantitative study of yeast growth in the presence of added ethanol and methanol using a calorimetric approach. Biosci Biotechnol Biochem 1997; 61: 664-669.
15. Mikulska M, Viscoli C. Current role of echinocandins in the management of invasive aspergillosis. Curr Infect Dis Rep 2011; 13: 517-527.
16. Lewis JS. Echinocandin activity against Aspergillus spp. and the importance of pharmacodynamics. Med Mycol 2009; 47 (suppl 1): S376-S381.
17. Garcia-Effron G, Mellado E, Gomez-Lopez A, Alcazar-Fuoli L, Cuenca-Estrella M, Rodriguez-Tudela JL. Differences in interactions between azole drugs related to modifications in the 14-alpha sterol demethylase gene (cyp51A) of Aspergillus fumigatus. Antimicrob Agents Chemother 2005; 49: 2119-2121.
18. Mellado E, Garcia-Effron G, Buitrago MJ, Alcazar-Fuoli L, Cuenca-Estrella M, Rodriguez-Tudela JL. Targeted gene disruption of the 14-alpha sterol demethylase (cyp51A) in Aspergillus fumigatus and its role in azole drug susceptibility. Antimicrob Agents Chemother 2005; 49: 2536-2538.
19. Verweij PE, Howard SJ, Melchers WJ, Denning DW. Azole-resistance in Aspergillus: proposed nomenclature and breakpoints. Drug Resist Updat 2009; 12: 141-147.
20. Pfaller MA, Boyken L, Hollis RJ et al. In vitro susceptibility of clinical isolates of Aspergillus spp. to anidulafungin, caspofungin, and micafungin: a head-to-head comparison using the CLSI M38-A2 broth microdilution method. J Clin Microbiol 2009; 47: 3323-3325.